dr. mohamad aimanuddin bin mohtar

pensyarah universiti

institut perubatan molekul (umbi)

No. rasmi:
UKM : 03 8921 5555



   Biografi/ Biography :

  • M. Aiman Mohtar is a Research Fellow at the UKM Medical Molecular Biology Institute (UMBI), The National University of Malaysia. He previously earned his BSc. (Biotechnology) with highest honours from Rochester Institute of Technology, New York and MSc. (Molecular Biology) from University of Pennsylvania, Philadelphia. He completed his PhD in Molecular and Clinical Medicine at Institute of Genetics and Molecular Medicine, University of Edinburgh. His PhD thesis focuses on identification of protein-protein interaction network of an oncogenic ER-resident protein. He has been trained as molecular biologist for more than a decade and has involved in research utilizing cutting- edge laboratory techniques such as CRISPR-Cas9 gene editing tools, fluorescence microscopy, phage display and quantitative proteomics. Aiman’s current research focus is studying protein-protein interaction and tumour cell secretory addiction in AGR2 signalling axis using multi-omics approach and developing therapeutic tools targeting pro-oncogenic molecules.

  • asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;reena rahayu binti md zin;soon bee hong;low teck yew.  (2022).  quantitative mass spectrometry analysis of cell surface proteins of cancer cell induced by the reconstitution of the pro-oncogenic anterior gradient-2 protein. .  -

     

    low teck yew;mohd firdaus bin mohd raih;saiful effendi bin syafruddin;mohamad aimanuddin bin mohtar;lee pey yee.  (2022).  elucidating the mechanism of secretion for human pro-metastatic agr2 protein.  -

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 principles, applications and ethical issues.  - 1-61. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 experimental workflow part i.  - 1-81. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    nisa syakila a. rahman, syazalina zahari, saiful effendi syafruddin, mohd firdaus-raih, teck yew low, m. aiman mohtar.  (2022).  functions and mechanisms of protein disulfide isomerase family in cancer emergence.  - cell & bioscience.  1-19. 

     

    teck yew low, saiful effendi syafruddin, m. aiman mohtar, adaikkalam vellaichamy, nisa syakila a rahman, yuh-fen pung & chris soon heng tan.  (2021).  recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions.  - cellular and molecular life sciences.  5325-5339. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, wan fahmi wan mohamad nazarie, nurshahirah ashikin moidu, bee hong soon, m. aiman mohtar.  (2021).  integration of rna-seq and proteomics data identifies glioblastoma multiforme surfaceome signature.  - bmc cancer.  1-13. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    nisa syakila a. rahman, syazalina zahari, saiful effendi syafruddin, mohd firdaus-raih, teck yew low, m. aiman mohtar.  (2022).  functions and mechanisms of protein disulfide isomerase family in cancer emergence.  - cell & bioscience.  1-19. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;reena rahayu binti md zin;soon bee hong;low teck yew.  (2022).  quantitative mass spectrometry analysis of cell surface proteins of cancer cell induced by the reconstitution of the pro-oncogenic anterior gradient-2 protein. .  -

     

    low teck yew;mohd firdaus bin mohd raih;saiful effendi bin syafruddin;mohamad aimanuddin bin mohtar;lee pey yee.  (2022).  elucidating the mechanism of secretion for human pro-metastatic agr2 protein.  -

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 principles, applications and ethical issues.  - 1-61. 

     

    abu bakar sulong, norfilza mohd mokhtar, mohamad nasir sahfiee, yap wei boon, caryn chan mei hsein, mohd kaisan mahadi, mohamad aimanuddin mohtar.  (2022).  impak: kluster kesihatan & perubatan termaju.  - impak: kluster kesihatan & perubatan termaju.  1-44. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 experimental workflow part i.  - 1-81. 

     
    dr. mohamad aimanuddin bin mohtar

    pensyarah universiti

    institut biologi molekul perubatan ukm (umbi)

     m.aimanmohtar@ppukm.ukm.edu.my

    No. Telefon Rasmi :  9062

    No. rasmi:
    UKM : 03 8921 5555



       Biografi/ Biography :

  • PENSYARAH UNIVERSITI

  • asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;reena rahayu binti md zin;soon bee hong;low teck yew.  (2022).  quantitative mass spectrometry analysis of cell surface proteins of cancer cell induced by the reconstitution of the pro-oncogenic anterior gradient-2 protein. .  -

     

    low teck yew;mohd firdaus bin mohd raih;saiful effendi bin syafruddin;mohamad aimanuddin bin mohtar;lee pey yee.  (2022).  elucidating the mechanism of secretion for human pro-metastatic agr2 protein.  -

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 principles, applications and ethical issues.  - 1-61. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 experimental workflow part i.  - 1-81. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    nisa syakila a. rahman, syazalina zahari, saiful effendi syafruddin, mohd firdaus-raih, teck yew low, m. aiman mohtar.  (2022).  functions and mechanisms of protein disulfide isomerase family in cancer emergence.  - cell & bioscience.  1-19. 

     

    teck yew low, saiful effendi syafruddin, m. aiman mohtar, adaikkalam vellaichamy, nisa syakila a rahman, yuh-fen pung & chris soon heng tan.  (2021).  recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions.  - cellular and molecular life sciences.  5325-5339. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, wan fahmi wan mohamad nazarie, nurshahirah ashikin moidu, bee hong soon, m. aiman mohtar.  (2021).  integration of rna-seq and proteomics data identifies glioblastoma multiforme surfaceome signature.  - bmc cancer.  1-13. 

     

    asmaa y. abuhamad, nurul nadia mohamad zamberi, ling sheen, safaa m. naes, siti nur hasanah mohd yusuf, asilah ahmad tajudin, m. aiman mohtar, amir syahir amir hamzah, saiful effendi syafruddin.  (2022).  reverting tp53 mutation in breast cancer cells: prime editing workflow and technical considerations.  - cells.  1-16. 

     

    alyssa zi-xin leong, pey yee lee, m. aiman mohtar, saiful effendi syafruddin, yuh-fen pung and teck yew low.  (2022).  short open reading frames (sorfs) and microproteins: an update on their identification and validation measures.  - journal of biomedical science.  1-15. 

     

    nisa syakila a. rahman, syazalina zahari, saiful effendi syafruddin, mohd firdaus-raih, teck yew low, m. aiman mohtar.  (2022).  functions and mechanisms of protein disulfide isomerase family in cancer emergence.  - cell & bioscience.  1-19. 

     

    siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  pdgfb paracrine signalling fuels growth promoting-mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - malaysian journal of medicine and health sciences.  46. 

     

    malak hassn mesrati, saiful effendi syafruddin, m. aiman mohtar, amir syahir.  (2021).  cd44: a multifunctional mediator of cancer progression.  - biomolecules.  1-32. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;reena rahayu binti md zin;soon bee hong;low teck yew.  (2022).  quantitative mass spectrometry analysis of cell surface proteins of cancer cell induced by the reconstitution of the pro-oncogenic anterior gradient-2 protein. .  -

     

    low teck yew;mohd firdaus bin mohd raih;saiful effendi bin syafruddin;mohamad aimanuddin bin mohtar;lee pey yee.  (2022).  elucidating the mechanism of secretion for human pro-metastatic agr2 protein.  -

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 principles, applications and ethical issues.  - 1-61. 

     

    abu bakar sulong, norfilza mohd mokhtar, mohamad nasir sahfiee, yap wei boon, caryn chan mei hsein, mohd kaisan mahadi, mohamad aimanuddin mohtar.  (2022).  impak: kluster kesihatan & perubatan termaju.  - impak: kluster kesihatan & perubatan termaju.  1-44. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 experimental workflow part i.  - 1-81.